← Back to Clinical Trials
Recruiting NCT07696390

NCT07696390 The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07696390
Status Recruiting
Phase —
Sponsor Yuzuncu Yil University
Condition Myocardial Infarction
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-07-10
Primary Completion 2026-09-18

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 70 Years
Study Type INTERVENTIONAL
Interventions
virtual reality glasses

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2026-07-10 with a primary completion date of 2026-09-18.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients diagnosed with myocardial infarction and admitted to the cardiology intensive care unit.

Eligibility Criteria

Inclusion Criteria: 1. The patient is in intensive care. 2. The patient has been diagnosed with myocardial infarction. 3. The patient is between 18 and 70 years old. 4. The patient is conscious. 5. The patient is oriented and cooperative. 6. The patient volunteers to participate in the study. 7. The patient is open to communication. 8. The patient agrees to participate in the study. 9. The patient has no mental, visual, auditory, or speech impairment. 10. The patient has undergone stent placement. 11. The patient has STEMI. Exclusion Criteria: 1. The patient has a psychiatric disorder. 2. The patient has any communication impairment.

Contact & Investigator

Central Contact

Yavuz Uren, Asst.Prof.

✉ yavuzuren@yyu.edu.tr

📞 +905065961050

Principal Investigator

Yavuz Uren, Asst.Prof

STUDY CHAIR

Van Yuzuncu Yil Universty

Frequently Asked Questions

Who can join the NCT07696390 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07696390 currently recruiting?

Yes, NCT07696390 is actively recruiting participants. Contact the research team at yavuzuren@yyu.edu.tr for enrollment information.

Where is the NCT07696390 trial being conducted?

This trial is being conducted at Van, Turkey (Türkiye).

Who is sponsoring the NCT07696390 clinical trial?

NCT07696390 is sponsored by Yuzuncu Yil University. The principal investigator is Yavuz Uren, Asst.Prof at Van Yuzuncu Yil Universty. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology